ATG7 and non-small cell lung carcinoma: To discriminate these two possibilities, NSCLC cells were treated with ALO in the presence of SAR405 or small interfering RNA (siRNA) targeting ATG7, which inhibits early‐stage autophagy by suppressing autophagosome formation, or bafilomycin A1 (BafA1), which inhibits late‐stage autophagy by impairing lysosomal degradation.